. Author manuscript; available in PMC: 2011 Jun 1.

Published in final edited form as: J Subst Abuse Treat. 2010 Feb 25;38(4):317–327. doi: 10.1016/j.jsat.2010.01.007

Table 2.

Bivariate associations between predictor domains and commitment to abstinence at the end of outpatient treatment: Total sample and Gender subgroups

	Total sample n = 250	Males n = 143	Females n = 107

Control variables
Male gender	-.19^**
Age (years)	.14^*	.14	.13
Education (years completed)	.11	.09	.16
African American	.14^*	.12	.17
Hispanic	-.13^*	-.09	-.19^*
Baseline Commitment to abstinence	.49^***	.53^***	.38^***
Predictor variables^a
No. of previous SUD treatment at intake	.04	.13	-.09
Mandated to index episode (yes) at intake	-.09	-.10	.03
Length of treatment stay (in days)	.17^**	.11	.17
Overall helpfulness of index episode	.24^**	.20^*	.27^**
Dependence severity (MINI) since baseline	-.15^*	-.07	-.25^**
Number of days drug problems past month	-.16^*	-.10	-.25^*
Cravings/temptation to use drugs	-.16^*	-.15	-.15
Perceived harm of future drug use	.43^***	.48^***	.33^**
Drug abstinence self-efficacy	.52^***	.51^***	.51^***
Perceived stress	-.18^**	-.20^*	-20^**
Quality of life satisfaction	.32^***	.26^**	.37^***
Psychological ASI	.05	.08	-.07
Perceived social support for recovery	.36^***	.36^***	.38^***
Number of network members in 12-step	.32^***	.33^***	.31^**
Number of 12-step meetings attended during treatment	.19^**	.21^*	.14
Level of involvement in 12-step activities	.34^***	.33^***	.33^***

^†

p <.1 [trend]

p <.05

^**

p <.01

^***

p <.001

Assessed at treatment end with the exception of prior treatment history and mandated status that were assessed at baseline